Alkem Laboratories board to consider final dividend

17 May 2017 Evaluate

Alkem Laboratories has informed that a meeting of the Board of Directors of the Company is scheduled to be held on May 26, 2017, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017; and to consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5416.65 -15.20 (-0.28%)
23-Dec-2024 09:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.35
Dr. Reddys Lab 1356.30
Cipla 1466.75
Lupin 2148.60
Zydus Lifesciences 969.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.